One of the first studies on the role of CX3CR1 in Alzheimer’s disease used CX3CR1-KO mice that were crossed with a triple-transgenic mouse model carrying presenilin, APP, and tau mutations. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.